Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Pablo Vial et al.
Summary: This study conducted a seroprevalence survey in three urban centers of Chile to estimate the prevalence of SARS-CoV-2 antibodies and model its spatial risk distribution. The results showed transmission heterogeneity of SARS-CoV-2 within and across the cities, with significant differences in infection risk by census zone. The findings highlight the importance of socio-economic factors in determining priority areas for intervention and can help inform strategies for controlling communicable diseases in urban contexts.
BMC INFECTIOUS DISEASES
(2022)
Article
Microbiology
Hongjie Xia et al.
Summary: Two doses of the BNT162b2 mRNA vaccine demonstrate high efficacy against SARS-CoV-2 and also provide neutralization against Omicron SARS-CoV-2. The study shows that the neutralization response improves with the third dose, but decreases slightly after four months.
CELL HOST & MICROBE
(2022)
Article
Medicine, General & Internal
Victoria Hall et al.
Summary: This study investigated the duration and effectiveness of immunity among healthcare workers in the United Kingdom. It found that two doses of the BNT162b2 vaccine provided high short-term protection against SARS-CoV-2 infection, but this protection significantly decreased after six months. However, infection-acquired immunity boosted by vaccination remained high, even more than one year after infection.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Editorial Material
Immunology
Nathan Duarte et al.
Summary: Population-level immune surveillance, including serosurveys, is crucial for public health decision-making during a pandemic. Serosurveys can provide valuable information on the prevalence of antibodies, distinguish infection and vaccine-induced immune responses, and guide vaccine distribution and booster dose needs.
OPEN FORUM INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Denis Saure et al.
Summary: The study in Chile found that individuals who received the CoronaVac vaccine had a lower IgG seropositivity compared to those who received the BNT162b2 vaccine. Over time, the IgG seropositivity for CoronaVac recipients declined, while those who received BNT162b2 maintained high levels of IgG positivity. Further monitoring of IgG levels will help in evaluating vaccine effectiveness and exploring potential adjustments to vaccination strategies in the future.
LANCET INFECTIOUS DISEASES
(2022)
Article
Multidisciplinary Sciences
Teklay Gebrecherkos et al.
Summary: This study characterizes the longitudinal antibody response to SARS-CoV-2 in Ethiopian COVID-19 patients, revealing heterogeneous responses. Little is known about the dynamics of SARS-CoV-2 serology in African settings, highlighting the need for further research.
Article
Public, Environmental & Occupational Health
Kristie E.N. Clarke et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2022)
Article
Public, Environmental & Occupational Health
Divya Nair et al.
Summary: This study aims to understand the burden of COVID-19 in urban and rural Indian populations through sero-epidemiological studies, guide monitoring of SARS-CoV-2 infection transmission trends, and identify infection risk factors to inform future control strategies.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Immunology
Michael P. Busch et al.
Summary: Substantial increases in population humoral immunity from SARS-CoV-2 infection, COVID-19 vaccination, and hybrid immunity were observed in the US in 2021.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Immunology
Parham Sendi et al.
Summary: This study assesses the COVID-19 risk among police officers and demonstrates the effectiveness of vaccination in reducing the infection rate. The study population had a 6-month infection rate of 1.8%, lower than the general population. Vaccinated participants showed a decreasing trend in antibody titers 150-200 days after the second dose.
IMMUNITY INFLAMMATION AND DISEASE
(2022)
Article
Infectious Diseases
Jesus Castilla et al.
Summary: In May 2022, the seroprevalence of anti-nucleocapsid and anti-spike antibodies of SARS-CoV-2 in Navarre, Spain was 58.9% and 92.7% respectively. The incidence of confirmed COVID-19 cases from then until July was lower in individuals with anti-N antibodies but showed no difference in those with anti-S antibodies. Hybrid immunity, including anti-N antibodies induced by natural exposure to SARS-CoV-2, appears to be essential in preventing Omicron COVID-19 cases.
Article
Allergy
Emma Rey-Jurado et al.
Summary: This study investigated the immune response and clinical features of Chilean patients with acute MIS-C, and identified biomarkers associated with the disease. The study found that MIS-C patients had T-cell activation and cytokine storm, and identified biomarkers associated with shock and KD-like MIS-C. Additionally, the study discovered a persistent defect in natural killer cell degranulation and gastrointestinal involvement in MIS-C patients. The findings provide valuable insights into immune dysregulation in MIS-C and identify biomarkers that could predict disease severity and organ involvement.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Elaine Cristina de Oliveira et al.
Summary: This study conducted a population-based serological survey in ten municipalities in Mato Grosso State, Brazil, and estimated the prevalence of COVID-19 to be 12.5%. The results showed no significant differences in infection prevalence based on race/color, education, or family income, but lower prevalence was observed in individuals living with a pensioner, not receiving emergency financial aid, and whose family income did not decrease after social distancing measures.
CADERNOS DE SAUDE PUBLICA
(2022)
Article
Medicine, General & Internal
Daniela Gornyk et al.
Summary: This study revealed that the seroprevalence rate of COVID-19 among unvaccinated individuals in various districts in Germany increased from 1.3-2.8% between July and December 2020 to 4.1-13.1% between February and May 2021. The seroprevalence rate showed a downward trend over the course of the pandemic.
DEUTSCHES ARZTEBLATT INTERNATIONAL
(2021)
Review
Infectious Diseases
Susanne H. Hodgson et al.
Summary: The development of a vaccine for the novel coronavirus is crucial to prevent the spread of the pandemic and reduce disease mortality. The efficacy endpoint is protection against severe disease and death, but evaluating this in phase 3 clinical trials poses challenges.
LANCET INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Joseph E. Ebinger et al.
Summary: This study aimed to determine the seroprevalence of SARS-CoV-2 among healthcare workers in Los Angeles and found a seroprevalence rate of 4.1%. Anosmia was the most prominently associated symptom, followed by fever and myalgias. Factors such as Hispanic ethnicity, African-American race, and contact with COVID-19-diagnosed individuals were also associated with seropositivity.
Article
Infectious Diseases
Mario Poljak et al.
Summary: The study in Slovenia showed a four-fold increase in SARS-CoV-2 seroprevalence from late April to October/November 2020 due to a devastating second wave. Significant logistic and methodological challenges were encountered in both rounds. Caution is needed when relying on manufacturer-generated assay evaluation data, and the importance of multiple manufacturer-independent assay performance assessments is highlighted in low-prevalence settings or during epidemic exponential growth.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Infectious Diseases
Muhammad Imran Nisar et al.
Summary: This study conducted three cross-sectional surveys in Karachi, Pakistan, revealing different seroprevalence rates of COVID-19 in various areas and highlighting the prevalence of asymptomatic infections. Ongoing seroprevalence studies will contribute to a better understanding of the trends and extent of infection during the pandemic.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Public, Environmental & Occupational Health
Saverio Bellizzi et al.
Summary: The evolution of the COVID-19 pandemic in Jordan went through three distinct phases, with a nationwide sero-prevalence survey showing a rapid increase in seroprevalence over time, reaching one-third of the population exposed to the virus by the end of 2020. Non-age-specific trends were observed in infection rates, with the majority of infected individuals being asymptomatic. The insights gained from serial cross-sectional surveys in Jordan will be valuable for planning public health mitigation measures like vaccinations and tailored restriction policies.
Article
Multidisciplinary Sciences
Gonzalo Mena et al.
Summary: The COVID-19 pandemic has disproportionately impacted cities, with a strong association found between socioeconomic status and both disease incidence and mortality. People in lower socioeconomic municipalities were less likely to adhere to lockdown measures and faced higher testing delays and positivity rates. This highlights the critical consequences of socioeconomic inequalities on health outcomes.
Review
Medicine, General & Internal
Rebecca Grant et al.
Summary: This study reviewed 23 population-based SARS-CoV-2 seroprevalence studies conducted in Europe, finding that the level of infection is much higher than the officially reported cases. Exposure to the virus in Europe has not reached a level that would prevent further circulation of the virus, highlighting the urgent need for effective vaccine candidates to provide population immunity.
Article
Medicine, General & Internal
Marina Pollan et al.
Editorial Material
Chemistry, Physical
Debby van Riel et al.
Article
Immunology
Patricia Figueiredo-Campos et al.
EUROPEAN JOURNAL OF IMMUNOLOGY
(2020)
Article
Environmental Sciences
Armando De Carlo et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2020)
Article
Medicine, General & Internal
E. S. Mayne et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL
(2020)
Editorial Material
Medicine, General & Internal
C. Jessica E. Metcalf et al.
Article
Public, Environmental & Occupational Health
Neus Cardenosa Marin
REVISTA ESPANOLA DE SALUD PUBLICA
(2009)
